J E Bernstein, A L Lorincz. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » AnimalsChancroid/drug therapyConjunctivitis, Inclusion/drug therapyDapsone/adverse effectsDapsone/pharmacologyDapsone/therapeutic useDermatitis Herpetiformis/drug therapyErythrocytes/drug effectsGlucosephosphate Dehydrogenase Deficiency/complicationsHumansLeprosy/drug therapyMaleMethemoglobinemia/chemically inducedMiceNocardia Infections/drug therapyPyoderma/drug therapyRatsSkin Diseases/drug therapySulfonamides/adverse effectsSulfonamides/pharmacologySulfonamides/therapeutic useTrachoma/drug therapy
Substances: See more » SulfonamidesDapsone
Year: 1981 PMID: 7012050 DOI: 10.1111/j.1365-4362.1981.tb00406.x
Source DB: PubMed Journal: Int J Dermatol ISSN: 0011-9059 Impact factor: 2.736